Proleukin (aldesleukin) - Iovance Biotherap
Aerosolized Aldesleukin in Treating Patients With Lung Metastases (clinicaltrials.gov) - Oct 16, 2026 - P1/2 | N=70 | Active, not recruiting | Sponsor: M.D. Anderson Cancer Center | Phase classification: P1 ➔ P1/2 
Phase classification • Cutaneous Melanoma • Genito-urinary Cancer • Lung Cancer • Melanoma • Oncology • Osteosarcoma • Renal Cell Carcinoma • Sarcoma • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT01590069
 
Oct 16, 2026
 
Prev Next